Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy

Photothermal therapy can induce an anti-tumour immune response by producing tumour-associated antigens. Here, the authors design a nanoparticle that simultaneously acts as a photothermal agent and an immune-adjuvant and demonstrate the anti-tumour efficacy in combination with anti-CTLA4 therapy in p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qian Chen, Ligeng Xu, Chao Liang, Chao Wang, Rui Peng, Zhuang Liu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2016
Materias:
Q
Acceso en línea:https://doaj.org/article/9e9e6fa3c41a409f8b926964a73429b3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9e9e6fa3c41a409f8b926964a73429b3
record_format dspace
spelling oai:doaj.org-article:9e9e6fa3c41a409f8b926964a73429b32021-12-02T14:39:14ZPhotothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy10.1038/ncomms131932041-1723https://doaj.org/article/9e9e6fa3c41a409f8b926964a73429b32016-10-01T00:00:00Zhttps://doi.org/10.1038/ncomms13193https://doaj.org/toc/2041-1723Photothermal therapy can induce an anti-tumour immune response by producing tumour-associated antigens. Here, the authors design a nanoparticle that simultaneously acts as a photothermal agent and an immune-adjuvant and demonstrate the anti-tumour efficacy in combination with anti-CTLA4 therapy in preclinical murine cancer models.Qian ChenLigeng XuChao LiangChao WangRui PengZhuang LiuNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-13 (2016)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Qian Chen
Ligeng Xu
Chao Liang
Chao Wang
Rui Peng
Zhuang Liu
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
description Photothermal therapy can induce an anti-tumour immune response by producing tumour-associated antigens. Here, the authors design a nanoparticle that simultaneously acts as a photothermal agent and an immune-adjuvant and demonstrate the anti-tumour efficacy in combination with anti-CTLA4 therapy in preclinical murine cancer models.
format article
author Qian Chen
Ligeng Xu
Chao Liang
Chao Wang
Rui Peng
Zhuang Liu
author_facet Qian Chen
Ligeng Xu
Chao Liang
Chao Wang
Rui Peng
Zhuang Liu
author_sort Qian Chen
title Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
title_short Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
title_full Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
title_fullStr Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
title_full_unstemmed Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
title_sort photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
publisher Nature Portfolio
publishDate 2016
url https://doaj.org/article/9e9e6fa3c41a409f8b926964a73429b3
work_keys_str_mv AT qianchen photothermaltherapywithimmuneadjuvantnanoparticlestogetherwithcheckpointblockadeforeffectivecancerimmunotherapy
AT ligengxu photothermaltherapywithimmuneadjuvantnanoparticlestogetherwithcheckpointblockadeforeffectivecancerimmunotherapy
AT chaoliang photothermaltherapywithimmuneadjuvantnanoparticlestogetherwithcheckpointblockadeforeffectivecancerimmunotherapy
AT chaowang photothermaltherapywithimmuneadjuvantnanoparticlestogetherwithcheckpointblockadeforeffectivecancerimmunotherapy
AT ruipeng photothermaltherapywithimmuneadjuvantnanoparticlestogetherwithcheckpointblockadeforeffectivecancerimmunotherapy
AT zhuangliu photothermaltherapywithimmuneadjuvantnanoparticlestogetherwithcheckpointblockadeforeffectivecancerimmunotherapy
_version_ 1718390729640771584